Vandana Mahajan, Palliative Care Counselor, Patient advocate, Cancer survivor, shared Lung Connect India’s post on LinkedIn, adding:
“Immunotherapy for Lung Cancer. At our 154th support group meeting, Dr. Ravikrishna Mandala presented a comprehensive overview of immunotherapy for lung cancer, addressing:
- The immune system’s role and how cancer cells evade it.
- Immunotherapy’s definition and its application in lung cancer treatment.
- Different immunotherapy drugs used in lung cancer treatment
- A comparison of immunotherapy and chemotherapy.
- PDL1 expression and its implications for immunotherapy.
- Expected side effects and their contrast with chemotherapy-related side effects.
- The justification for concurrent administration of chemotherapy and immunotherapy in certain cases.
Knowledge is power. Educating families dealing with a lung cancer diagnosis empowers them. If they know what they are dealing with, compliance to treatment is also better.
At LUNG Connect, our endeavour is to simplify the complex lung cancer journey.
Thank you Dr Ravi Krishna for your continued support to us.”
Quoting Lung Connect India’s post:
“Lung Connect India Foundation successfully concluded its 154th Support Group Meeting- Mumbai Chapter.”
More posts featuring Vandana Mahajan.